Keyphrases
Tumor Immunity
100%
Ewing Sarcoma
100%
Cyclin-dependent Kinase 4 (CDK4)
100%
Oncolytic Adenovirus
100%
Adaptive Antitumor Immunity
100%
T Cells
60%
Immunogenicity
60%
Combined Method
40%
Viral Replication
40%
Tumor Infiltration
40%
YB-1
40%
Novel Combinations
20%
Therapeutic Potential
20%
Combination Treatment
20%
Innate Immunity
20%
Antigen-presenting
20%
Humanization
20%
Interferon-γ
20%
Dendritic Cells
20%
Adaptive Immunity
20%
M1 Macrophages
20%
Dendritic Cell Maturation
20%
Adenovirus Infection
20%
Metastasizing
20%
Engraftment
20%
Monocytes
20%
Immune Evasion
20%
Sarcoma Cells
20%
Monocytic
20%
Abscopal Effect
20%
Antitumor Effect
20%
Immunological Characteristics
20%
Pediatric Tumors
20%
Tumor Control
20%
Superior Capacity
20%
Tumor Xenograft Model
20%
Joint Force
20%
HLA-I
20%
Viral Dynamics
20%
Treg Suppression
20%
T Cell-inflamed
20%
Viral Toxicity
20%
Novel Treatments
20%
Tumor Antigen-specific T Cell
20%
Innate-like T Cells
20%
Macrophage Marker Genes
20%
Viral Oncolysis
20%
Medicine and Dentistry
T Cell
100%
Ewing Sarcoma
100%
Oncolytic Adenovirus
100%
Neoplasm
60%
Immunogenicity
60%
In Vitro
40%
Dendritic Cell
40%
Adaptive Immunity
20%
Maturation
20%
Marker Gene
20%
Viral Replication Control
20%
Virus Replication
20%
Macrophage
20%
Adenovirus Infection
20%
Engraftment
20%
Upregulation
20%
Tumor Antigen
20%
Tumor Xenograft
20%
Pediatric Cancer
20%
Ewing Sarcoma Cell Line
20%
Abscopal Effect
20%
Cell Maturation
20%
Immunology and Microbiology
Oncolytic Adenovirus
100%
T Cell
100%
Immunogenicity
60%
Dendritic Cell
40%
Adaptive Immune System
20%
Viral Replication
20%
Regulatory T Cell
20%
Engraftment
20%
Xenograft
20%
Macrophage
20%
Viral Replication Control
20%
Dynamics
20%
Cell Maturation
20%
Adenoviridae
20%
Maturation
20%
Marker Gene
20%
Upregulation
20%
Ewing Sarcoma Cell Line
20%
Tumor Antigen
20%